Clinical trials: Intestinal Failure

Short Bowel Syndrome

Metabolic Balance Study of Apraglutide in Patients With Short Bowel Syndrome, Intestinal Failure (SBS-IF) and Colon-in-Continuity (CIC)

• Completed
• Age: 18 years and older
• Phase 2
• Injection or infusion
• Results posted

The primary objective of the trial is to evaluate the safety of apraglutide in adult subjects with SBS-IF and CIC.

Trial name

STARSnutrition (NCT04964986)

Testing

Apraglutide

Where

2 sites in Belgium, France

Volunteers

10 people

Sponsor

VectivBio AG